Candid Therapeutics
Clinical trials sponsored by Candid Therapeutics, explained in plain language.
-
New drug cizutamig enters early trial for thyroid eye disease
Disease control Recruiting nowThis early-stage trial is testing a new drug called cizutamig in 38 adults with active, moderate-to-severe thyroid eye disease. The main goal is to see if the drug is safe and tolerable, while also checking how the body processes it and whether it shows any signs of helping the c…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New lupus drug cizutamig enters early human safety trials
Disease control Recruiting nowThis early-stage study is testing a new drug called cizutamig in about 47 adults with systemic lupus erythematosus (SLE), a chronic autoimmune disease. The main goal is to check if the drug is safe and tolerable, and to see how it moves through the body. Participants must have ac…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug hope for muscle weakness disease enters early human testing
Symptom relief Recruiting nowThis early-phase study tests a new drug called cizutamig in 44 adults with generalized myasthenia gravis, a condition causing muscle weakness. The main goal is to check safety and how the body processes the drug. Participants must have moderate symptoms and not have responded wel…
Phase: PHASE1 • Sponsor: Candid Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC